Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3A | P49840 | 1/20 | 0.64 |
| ▸ | GSK3B | P49841 | 1/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | HPGD | P15428 | 2/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.51 |
| ▸ | BLM | P54132 | 1/20 | 0.51 |
| ▸ | WRN | Q14191 | 1/20 | 0.51 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.51 |
| ▸ | PTGS1 | P23219 | 7/20 | 0.50 |
| ▸ | PTGS2 | P35354 | 7/20 | 0.50 |
| ▸ | MGLL | Q99685 | 4/20 | 0.50 |
| ▸ | FAAH | O00519 | 3/20 | 0.50 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.48 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | PKM | P14618 | 1/20 | 0.48 |
| ▸ | XBP1 | P17861 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5165588 | 0.93 | PTGS1 (0.60) | GSK3AGSK3BALDH1A1HPGDCYP1A2 | |
| SCHEMBL5165278 | 0.93 | PTGS1 (0.60) | GSK3AGSK3BALDH1A1HPGDCYP1A2 | |
| SCHEMBL5165325 | 0.89 | GSK3A (0.68) | GSK3AGSK3BALDH1A1HPGDCYP1A2 | |
| SCHEMBL5164273 | 0.87 | MAPT (0.58) | GSK3AGSK3BALDH1A1HPGDCYP1A2 | |
| SCHEMBL5160668 | 0.85 | MAPK1 (0.59) | GSK3AGSK3BALDH1A1HPGDCYP1A2 | |
| SCHEMBL5166261 | 0.84 | PTGS1 (0.57) | GSK3AGSK3BALDH1A1HPGDCYP1A2 | |
| SCHEMBL15024126 | 0.83 | CYP3A4 (0.49) | GSK3AGSK3BALDH1A1HPGDCYP1A2 | |
| SCHEMBL15024044 | 0.83 | PTGS1 (0.60) | PTGS1PTGS2MGLLFAAHLMNA | |
| SCHEMBL15024067 | 0.83 | PTGS1 (0.60) | PTGS1PTGS2MGLLFAAHLMNA | |
| SCHEMBL5161619 | 0.82 | MGLL (0.54) | GSK3AGSK3BALDH1A1HPGDCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1582548-B1 | PROCESS FOR PRODUCING POLYMERIZABLE POLYBRANCHED POLYESTER | DAINIPPON INK & CHEMICALS (JP) | 2007-03-28 | — | — | EP | disclosed |
| CN-1303130-C | Process for producing polymerizable polybranched polyester | DAINIPPON INK & CHEMICALS (JP) | 2007-03-07 | — | — | CN | disclosed |
| US-7141642-B2 | Process for producing polymerizable polybranched polyester | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2006-11-28 | — | — | US | disclosed |
| US-20060047140-A1 | Process for producing polymerizable polybranched polyester | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2006-03-02 | — | — | US | disclosed |
| CN-1714113-A | Process for producing polymerizable polybranched polyester | DAINIPPON INK & CHEMICALS (JP) | 2005-12-28 | — | — | CN | disclosed |
| EP-1582548-A1 | PROCESS FOR PRODUCING POLYMERIZABLE POLYBRANCHED POLYESTER | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2005-10-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060047140-A1 | Process for producing polymerizable polybranched polyester | ACSL4, ACSL1, HACL2 | GSK3A 2879/4885GSK3B 3375/4885ALDH1A1 1751/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.